Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions
Community-Acquired Pneumonia (CAP)
Interventions
DRUG

Radezolid

300 mg/day, orally for 7-10 days

DRUG

Radezolid

450 mg/day orally for 7-10 days

DRUG

Radezolid

900 mg/day orally for 7-10 days

Trial Locations (30)

Unknown

eStudySite, San Diego

Olive View- UCLA Center, Dept. Emergency Medicine, Sylmar

Wayne State University School of Medicine/Detroit Receiving Hospital, Detroit

Arnold Markowitz, MD, Keego Harbor

Mercury Street Medical Group, LLC, Butte

Dr. John Bernard, Belvidere

University of Medicine & Dentistry of New Jersey, School of Osteopathic Medicine (UMDNJ-SOM), Cherry Hill

Warminster Medical Associates, P.C., Warminster

Ronald Collette, MD, Burnaby

The Medical Arts Health Research Group, Kelowna

Westview Research, North Vancouver

The Medical Arts Health Research Group, Penticton

Maritime Research Center, Bathurst

Source Unique Research, Hawkesbury

Gordon Schacter, MD, London

London East Medical Centre, London

SKDS Research Inc., Newmarket

University of Ottawa Health Services, Ottawa

London Road Diagnostic Clinic and Medical Centre, Sarnia

Kings County Medical Centre, Montague

Rhodin Recherche Clinique, Drummondville

Centre Medical Acadie, Montreal

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky, Moscow

Moscow State Medico-Stomatological University, Moscow

"State Healthcare Institution City Clinical Hospital # 29", Moscow

State Healthcare Institution Moscow, Moscow

City Hospital # 31, Saint Petersburg

St. Petersburg City Hospital # 26, Saint Petersburg

St. Petersburg Pavlov State Medical University, Saint Petersburg

St. Petersburg Scientific-Research Institute of Pulmonology at State Medical University named after Academician I.P. Pavlov, Saint Petersburg

Sponsors
All Listed Sponsors
lead

Melinta Therapeutics, Inc.

INDUSTRY

NCT00640926 - Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia | Biotech Hunter | Biotech Hunter